| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 03/22/2006 | CN1246035C Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 03/21/2006 | US7015203 Macrolides |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/16/2006 | WO2006027130A1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
| 03/16/2006 | US20060058306 Solubilized topoisomerase poison agents |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057150 Compositions against chicken coccidiosis |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | DE102004027871B3 Verfahren zur Herstellung von 10α-[4'-(S,S-Dioxothiomorpholin-1'-yl)]-10-desoxo-10-dihydroartemisinin Process for the preparation of 10α- [4 '- (S, S-Dioxothiomorpholin-1'-yl)] - 10-deoxo-10-dihydroartemisinin |
| 03/16/2006 | CA2580132A1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
| 03/15/2006 | EP1634079A1 Screening method for substances binding to merozoite surface protein-1/42 |
| 03/15/2006 | EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/15/2006 | CN1745762A Compound metrinidazole preparation and its making method thereof |
| 03/15/2006 | CN1245385C Indole and dihydroindole derivatives |
| 03/14/2006 | US7012079 (5R)-5-ethyl-9,10,difluoro-5-hydroxy-12-(2-trimethylsilylethyl)-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]-indoloizino[1,2-b]quinoline-3,15-dione for treatment of colon cancer |
| 03/14/2006 | US7012077 Anticholesterol agents; antilipemic agents |
| 03/14/2006 | CA2376748C Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 03/09/2006 | WO2006025425A1 Protein participating in inhibition of plasmodium growth |
| 03/09/2006 | WO2005110384A3 Apiary veterinary composition |
| 03/09/2006 | US20060052381 Solubilized topoisomerase poisons |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | CA2578184A1 Combination of substituted benzimidazoles and triazine derivatives with antiparasitic action |
| 03/08/2006 | EP1390377B1 New crystal form of azithromycin |
| 03/08/2006 | EP1353926B1 Mikanolide derivatives, their preparation and therapeutic uses |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same. |
| 03/08/2006 | EP1328527B1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents |
| 03/08/2006 | EP1123396B1 Minimal promoters and uses thereof |
| 03/08/2006 | EP1075265B1 Use of tetracyclines for treating meibomian gland disease |
| 03/08/2006 | EP0988310B9 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 03/08/2006 | CN1742810A Medicine composition for treating malaria |
| 03/08/2006 | CN1244322C Use of inhibitors of sodium-hydrogen exchanging pump for production of medicine for treatment of disorders which are caused by protozoa |
| 03/07/2006 | US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections |
| 03/02/2006 | WO2006022562A1 Improved chemical delivery formulations |
| 03/02/2006 | DE102004031660A1 Agent to stimulate natural defenses against infection, in humans and/or mammals, is a microbial antigen-antitoxin combination in a variety of presentations |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628659A1 Use of poly-aminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis |
| 03/01/2006 | EP1628655A2 Antiseptic compositions, methods and systems |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1278520B1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 03/01/2006 | CN1742017A Antiprotozoal ring-substituted phospholipids |
| 03/01/2006 | CN1741815A 疟疾疫苗 Malaria Vaccine |
| 03/01/2006 | CN1739800A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/01/2006 | CN1739787A Orally administered peptides to ameliorate atherosclerosis |
| 03/01/2006 | CN1739542A Slowly releasing solid ivermectin microballoon prepn |
| 03/01/2006 | CN1739507A Medicine composition for treating mixed infectious disease |
| 03/01/2006 | CN1739506A Autoemulsified albendazole prepn and its prepn process |
| 03/01/2006 | CN1739504A L-ornidazole prepn |
| 03/01/2006 | CN1243767C Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 03/01/2006 | CN1243766C -’툷Á€-9-�ÐЧ-9A-Á¬ÈË-9A-©›‘ýå˜öÏAÐœ•·Ü´ |
| 03/01/2006 | CN1243551C Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 02/28/2006 | CA2373117C 13-methyl-erythromycin derivatives |
| 02/28/2006 | CA2173116C Ring-expanded nucleosides and nucleotides |
| 02/22/2006 | EP1627883A1 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A derivatives |
| 02/22/2006 | CN1738828A Avermectin b1 and avermectin b1 monosaccharide derivatives having an alkoxymethyl substituent in the 4''- or 4'-position |
| 02/22/2006 | CN1737008A Crystalline azithromycin, process for manufacture and pharmaceutical compositions thereof |
| 02/22/2006 | CN1242752C Ointment for curing brandy nose |
| 02/22/2006 | CN1242748C Animal medicine composition for preventing and treating coccidiosis |
| 02/21/2006 | US7001983 Non-hemolytic cytolytic peptides;antibacterial, anticancer, antiprotozoal agents |
| 02/21/2006 | US7001734 Process for identifying para cation channel modulators |
| 02/21/2006 | US7001718 Prevent complexing of Dna and ligand; viricides; drug mixture with carrier |
| 02/16/2006 | WO2005062748A3 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |
| 02/16/2006 | WO2003083058A3 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 02/16/2006 | US20060035839 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/15/2006 | CN1735431A Whole bacterial cells as immune modulator |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735414A Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 02/15/2006 | CN1733779A Novel phosphorus-containing prodrug |
| 02/15/2006 | CN1733723A Indole and dihydroindole derivatives |
| 02/15/2006 | CN1733699A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 02/15/2006 | CN1241907C Organic compounds |
| 02/15/2006 | CN1241639C Vaccine composition against malaria |
| 02/15/2006 | CN1241480C Pesticidal and antiparasitic compositions |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | CA2163197C Tri(platinum) complexes |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060030542 Protecting a muscarinic acetylcholine receptor in patient, by administering at least one pyrophosphates with active drug; prevent tissue damage, increasing the efficacy of a therapeutic agent |
| 02/08/2006 | EP1624063A2 Chimeric gene encoding the antigenic determinants of four proteins of L. infantum |
| 02/08/2006 | EP1623981A1 Anti-leishmania agent |
| 02/08/2006 | EP1623720A2 Vaccine composition against malaria |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1131292B1 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 02/08/2006 | CN1731988A Sustained release pharmaceutical composition |
| 02/08/2006 | CN1730072A Chinese traditional medicine formula for curing cysticercosis |
| 02/08/2006 | CN1240713C New compound |
| 02/08/2006 | CN1240681C Nitrile derivatives as cathepsin K inhibitors |
| 02/07/2006 | US6995185 Δ1-pyrrolines used as pesticides |
| 02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/07/2006 | US6994861 Antiprotozoa agents; parasiticides; prevention abortion in mammals |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024754 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 02/02/2006 | US20060024345 Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |